A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Neoadjuvant therapy and immunotherapy strategies for hepatocellular carcinoma
2020
American Journal of Cancer Research
Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality rate worldwide. Due to aggressive and invasive characteristics of HCC, poor prognosis is often displayed at advanced stages while therapeutic options are limited. Liver resection is still an essential curative-intent treatment in HCC management, while locoregional and systematic therapies made promising advances that may improve the proportion and outcomes of patients who are surgical candidates. In this
pmid:32642282
pmcid:PMC7339264
fatcat:hlaxsy7a55dyndwvqoecjtlo7e